TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The Food Dudes, Toronto's renowned culinary firm founded by Chef Adrian Niman, announced today an exclusive partnership with Compass Group Canada, the count
BOSTON, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
LONDON, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced
Shares of Compass have rallied after the company's strong Q2 earnings print, bringing YTD gains to above 20% and beating the S&P 500. Importantly, Compass CEO Robert Reffkin also claimed that Compass
WESTPORT, Conn., Aug. 26, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today that Stephen Keller
Robert Reffkin, Compass co-founder and CEO, joins 'Squawk on the Street' to discuss the housing markets as mortgage rates fall and new home sales rise.
WESTPORT, Conn., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Altor Solutions (“Altor”), a subsidiary of Compass Diversified (NYSE: CODI) and a leading designer and manufacturer of custom protective and cold
OVERLAND PARK, Kan.--(BUSINESS WIRE)--Compass Minerals (NYSE: CMP), a leading global provider of essential minerals, received written notice on August 15, 2024 from the New York Stock Exchange (NYSE)
NEW YORK , Aug. 8, 2024 /PRNewswire/ -- Compass, Inc. (NYSE: COMP) ("Compass" or "the Company"), the largest residential real estate company in the United States by sales volume [1] , announces that i
BOSTON, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to
LONDON and NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence-based innovation in men
Compass, Inc. (NYSE:COMP ) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Richard Simonelli - Senior & Vice President of Investor Relations Robert Reffkin - Founder & C
Compass, Inc. (COMP) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to loss of $0.10 per share a year ago.
WESTPORT, Conn., July 31, 2024 (GLOBE NEWSWIRE) -- Compass Diversified (NYSE: CODI) (“CODI” or the “Company”), an owner of leading middle market businesses, announced today its consolidated op
All-Time High Net Income of $20.7 million All-Time High Adjusted EBITDA of $77.4 million Free Cash Flow Positive for 4 of the Last 5 Quarters Increased Quarterly Market Share to 5.13% NEW YORK , July
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE